Rinaldetti, Sébastien <br/><br/>
Effect of ABCG2, OCT1, and ABCB1 (MDR1) Gene Expression on Treatment-Free Remission in a EURO-SKI Subtrial.  [electronic resource] 

 -  Clinical lymphoma, myeloma & leukemia  04 2018 
 - 266-271 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Multicenter Study 
<br/><br/><label>ISSN: </label>2152-2669 
<br/><br/><label>Standard No.: </label>10.1016/j.clml.2018.02.004  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>ATP Binding Cassette Transporter, Subfamily B--genetics<br/>ATP Binding Cassette Transporter, Subfamily G, Member 2--genetics<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Agents--administration & dosage<br/>Biomarkers, Tumor--genetics<br/>Disease-Free Survival<br/>Female<br/>Humans<br/>Kaplan-Meier Estimate<br/>Leukemia, Myelogenous, Chronic, BCR-ABL Positive--drug therapy<br/>Male<br/>Middle Aged<br/>Neoplasm Proteins--genetics<br/>Octamer Transcription Factor-1--genetics<br/>Pharmacogenomic Variants--genetics<br/>Protein Kinase Inhibitors--administration & dosage<br/>Remission Induction<br/>Transcriptome